In this study, the catalytic domain of bovine endothelin converting enzyme-1a (ECE-1a) was cloned into a baculovirus transfer vector behind the human alkaline phosphatase signal sequence. The recombinant baculovirus was then used to infect High FiveTM insect cells in suspension culture. Both the monomeric (85kDa) and dimeric (170kDa) forms of soluble ECE-1a were purified to electrophoretic homogeneity from concentrated culture media following sequential concanavalin A, SP-Sepharose, Mono Q and gel filtration column chromatography. Typically, approximately 11mg of ECE-1a monomer and 6mg of dimer were obtained from l litre of culture medium. No interconversion of the two forms was detected after purification. Both forms of ECE-1a had a pH optimum of 7.0, were maximally stimulated by NaCl at a concentration of 500mM, and were inhibited to the same extent by metalloprotease inhibitors such as phosphoramidon and EDTA. However, in kinetic studies using big endothelin-1 (ET-1) as a substrate, the Km and kcat values for the monomer were 2.2µM and 1.6min-1 respectively, while those of the dimer were 1.4µM and 4.9min-1 respectively. These results show that, although the two forms of ECE-1a behave similarly in many aspects, the dimeric enzyme is more efficient in catalysing the conversion of big ET-1 to ET-1. The present protocol can be utilized to prepare large quantities of both forms of ECE-1a for further biochemical and structural characterization.
Skip Nav Destination
Article navigation
September 2002
-
Cover Image
Cover Image
Conference Article|
September 01 2002
Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1a
Raviraj KULATHILA;
Raviraj KULATHILA
*Novartis Institute for Biomedical Research, 556 Morris Avenue, Summit, NJ 07901, U.S.A.
Search for other works by this author on:
Kirk CLARK;
Kirk CLARK
*Novartis Institute for Biomedical Research, 556 Morris Avenue, Summit, NJ 07901, U.S.A.
Search for other works by this author on:
Paula SAVAGE;
Paula SAVAGE
*Novartis Institute for Biomedical Research, 556 Morris Avenue, Summit, NJ 07901, U.S.A.
Search for other works by this author on:
Benjamin R. BOWEN;
Benjamin R. BOWEN
*Novartis Institute for Biomedical Research, 556 Morris Avenue, Summit, NJ 07901, U.S.A.
Search for other works by this author on:
Noriaki EMOTO;
Noriaki EMOTO
†Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75253, U.S.A.
Search for other works by this author on:
Masashi YANAGISAWA;
Masashi YANAGISAWA
†Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75253, U.S.A.
Search for other works by this author on:
Arco Y. JENG
*Novartis Institute for Biomedical Research, 556 Morris Avenue, Summit, NJ 07901, U.S.A.
Dr A.Y. Jeng, Bldg. 130, Room 2227, Novartis Pharmaceuticals Corporation, 556 Morris Avenue, Summit, NJ 07901, U.S.A. (e-mail arco.jeng@pharma.novartis.com).
Search for other works by this author on:
Clin Sci (Lond) (2002) 103 (s2002): 94S–97S.
Citation
Raviraj KULATHILA, Kirk CLARK, Paula SAVAGE, Benjamin R. BOWEN, Noriaki EMOTO, Masashi YANAGISAWA, Arco Y. JENG; Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1a. Clin Sci (Lond) 1 September 2002; 103 (s2002): 94S–97S. doi: https://doi.org/10.1042/CS103S094S
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.